Dr. Shaheda Siddiqui*, Dr. Sana Amreen, Khatija Saifuddin, Juweriya Tabassum, Syeda Afreen Nikhat and Dr. U. Narayan Reddy


Background: Pneumonia is an inflammation of the lung parenchyma caused by virus, bacteria, or fungi, in the alveoli (tiny air sacs) of infective origin and characterized by consolidation. Bronchopneumonia, or lobular pneumonia, is a type of pneumonia that causes inflammation in the bronchi. Aims and Objectives: Calculating the incidence of bronchopneumonia, studying the prescribing patterns of bronchopneumonia in pediatrics including the use of antibiotics according to the pathogens involved in the occurrence of the disease, educating parents about the importance of immunization (or) vaccination, finding the incidence after immunization against pathogen, identifying the predictors for developing bronchopneumonia. Hypothesis testing: Significance between age and gender: Null hypothesis: There is NO significant difference between the age groups of paediatrics population in occurrence of bronchopneumonia Alternative hypothesis: There is significant difference between the age groups of paediatrics population in occurrence of bronchopneumonia. Significance between use of antibiotics: Null hypothesis: There is NO significant difference in usage of antibiotics in treatment of bronchopneumonia. Alternative hypothesis: There is NO significant difference in usage of antibiotics in treatment of bronchopneumonia. METHODS: In-patients of paediatrics department diagnosed with bronchopneumonia. Statistical analysis: Incidence rate, Standard Deviation, Chi square test. Results: The incidence rate of bronchopneumonia-41% Incidence of bronchopneumonia after immunization-44.5% Teatment- Antibiotics, anti pyretics, secrelolytic agents, anti-histamines, bronchodialators, nebulisation and oxygen inhalation. Conclusion: In conclusion, our study reveals the prescription pattern of antibiotics and other drugs for bronchopneumonia along with incidence rate and risk factors. Antibiotics are widely prescribed for the treatment of bronchopneumonia especially monocef (2nd generation cephalosporins) was used habitually. Along with antibiotics, anti pyretics, anti-histamines, mucosecrolytic agents were also used. Resistance of antibiotics was seen in 71 patients. The utilization rates and resistance of antibiotics prescribed in paediatrics are matter of great concern and need to be urgently addressed by use of guidelines, protocols, educational initiatives and antibiotic restriction policies at all levels of health care. Educational programmes should be conducted for the awareness of importance of immunization and risk factors of bronchopneumonia for the patient attendees in paediatrics.

Keywords: Incidence, bronchopneumonia, severity of disease, immunization, prescription pattern, observational study.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2024 Issue has been successfully launched on 1 MAY 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction